Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net loss $ (13,049) $ (5,847)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 355 59
Provision for doubtful accounts 28 67
Amortization of debt discounts and issuance costs   2,054
Change in fair value of warrant liability   (3,118)
Share-based compensation expense 2,474 125
Changes in assets and liabilities:    
Accounts receivable (2,023) (2,915)
Expenditures billable to clients (900) (1,484)
Prepaid expenses and other current assets 541 (2,111)
Accounts payable (1,753) 4,328
Accrued media payments 913  
Client advances 1,763 4,012
Other accrued liabilities (1,597) (282)
Net cash used in operating activities (13,248) (5,112)
Cash flows from investing activities:    
Proceeds from sales of marketable securities 6,000  
Capital expenditures (1,693)  
Intangible assets acquired (70) (30)
Net cash provided by (used in) investing activities 4,237 (30)
Cash flows from financing activities:    
Proceeds from issuance of convertible notes payable   2,000
Common stock offering costs (64) (83)
Debt issuance costs   (15)
Proceeds from issuances of stock under employee stock plans 556  
Other   (56)
Net cash provided by financing activities 492 1,846
Net decrease in cash and cash equivalents (8,519) (3,296)
Cash and cash equivalents, beginning of period 29,545 12,078
Cash and cash equivalents, end of period $ 21,026 8,782
Non-cash financing activities:    
Unpaid deferred IPO costs   $ 263